Patient Takes First Steps After Spinal Cord Injury

By: UofLPhysicians

Continued here:
Patient Takes First Steps After Spinal Cord Injury - Video

Recommendation and review posted by sam

Spinal Cord Injury Attorney Los Angeles

By: OwenPattersonLaw

View original post here:
Spinal Cord Injury Attorney Los Angeles - Video

Recommendation and review posted by sam

Blue Hills Veterinary Hospital - Stem Cell Therapy Success
Visit http://www.bluehillsvet.co.za for more information.

By: Blue Hills Veterinary Hospital

Read the original here:
Blue Hills Veterinary Hospital - Stem Cell Therapy Success - Video

Recommendation and review posted by simmons

The Healing Powers of Regenerative Cell Therapy
Dr. Tess Mauricio, America #39;s favorite Dermatologist, and her team at M Beauty by Dr. Tess, in San Diego, California, have found measurable success rejuvenati...

By: HealthBeautyLifeShow

Originally posted here:
The Healing Powers of Regenerative Cell Therapy - Video

Recommendation and review posted by Bethany Smith

Royal Baby: The moment the notification of the royal baby was displayed at the Palace
The official notification of the royal birth was placed on an easel at Buckingham Palace today announcing that the Duchess of Cambridge has given birth to a ...

By: ITN

Read this article:
Royal Baby: The moment the notification of the royal baby was displayed at the Palace - Video

Recommendation and review posted by Bethany Smith

DOJ Pulls Funding From Youth Group Because Of Prayer Mention Faith - Wake Up America!
Obama Attack On Faith? DOJ Pulls Funding From Youth Group Because Of Prayer Mention Faith - Wake Up America!

By: Mass Tea Party

More here:
DOJ Pulls Funding From Youth Group Because Of Prayer

Recommendation and review posted by Bethany Smith

HIDEOUT - Genetics (Lyrics in description)
I do not own this. All rights reserved and stuff. Buy the No Rest EP on Bandcamp: http://hideoutny.bandcamp.com/album/no-rest Honestly, buy it. It #39;s worth th...

By: Matthis de Bruyn

Read more:
HIDEOUT - Genetics (Lyrics in description) - Video

Recommendation and review posted by Bethany Smith

Size Genetics - $141 Off Discount Code
Size Genetics: Click Here to buy SizeGenetics and save $141. If you are planning to buy sizegenetics extender I have some good news for, now you can save a l...

By: SizeGeneticsPro

Read more:
Size Genetics - $141 Off Discount Code - Video

Recommendation and review posted by Bethany Smith

FAQ4 A Scientific Basis for Stem Cell Therapy
http://youtu.be/uf_toA9Nzuo With all the hype online and in the media today, it is easy to believe that Stem Cell therapy is ALSO #39;hype #39;, but it actually eme...

By: Kerry Dean

See original here:
FAQ4 A Scientific Basis for Stem Cell Therapy - Video

Recommendation and review posted by Bethany Smith

SAN FRANCISCO, CA--(Marketwired - Jul 26, 2013) - Jason Kolbert, Managing Director of Maxim Group, stated in an interview with The Life Sciences Report, "Mesoblast Ltd. (ASX: MSB) (PINKSHEETS: MBLTY) did something very interesting in its phase 2 human clinical trial for DDD. It recruited steroid-refractory patients -- people who had already failed steroids for their pain. Therefore, the fact that cells showed a good result in these patients is very significant. We think the long-term use of steroids does nothing toward healing disc disease. Cell therapy opens up an entire new treatment paradigm in back pain."

The Life Sciences Report: "Does cell therapy have to be superior to current therapies, steroids in particular? Isn't it enough that cells won't cause steroid necrosis in the spine?"

Jason Kolbert: "Mesoblast went around the current therapy issue entirely by enrolling steroid-refractory patients in its trial. If it can demonstrate that cell therapy works in patients who have failed steroids, the company is dealing in a niche market, essentially an unmet medical need. That's huge.

Going forward, once Mesoblast has FDA approval, how would it extend the label for frontline usage? That's the question. Would it have to run a control arm against steroids and show noninferiority? That's more likely than being required to show superiority, particularly if it occurs in a sequence where it has already shown utility in steroid-refractory patients. That is the brilliance of the Mesoblast strategy."

Continue reading this interview with Jason Kolbert of Maxim Group: "Is Cell Therapy the 'Future of Medicine'?"

Read The Life Sciences Report's recent interview with Mesoblast Ltd.'s CEO, Silvio Itesco: "Mesoblast Ltd. Targets Success in the Degenerative Disc Space."

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Go here to see the original:
Is Cell Therapy the 'Future of Medicine'? The Life Sciences Report Interview With Jason Kolbert of Maxim Group

Recommendation and review posted by Bethany Smith

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xtvgc9/global_molecular) has announced the addition of the "Global Molecular Diagnostics Market Report: 2013 Edition" report to their offering.

Global Molecular Diagnostics Market Report: 2013 Edition

The molecular diagnostics procedures for infectious diseases including HPV, CT/NG; and the deadly gene linked cancer represent the largest market category in terms of revenue generation. Since the realm of cancer detection and screening procedures is undergoing a major change, the Oncology segment of the market is poised to undergo noteworthy expansion in the near future thereby driving the molecular diagnostics market on the holistic basis.

As of now, the global molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of Oncology and reimbursement trend. While the global molecular diagnostics marketplace remains marred by challenges like rising price pressures and growing regulatory hurdles; the underlying growth drivers including the ever increasing demand for better healthcare solutions, coupled with ageing world population, reimbursement, increasing insurance density, growing demand for genetic testing and rising new incidences of cancer, are taking the molecular diagnostics market to new heights.

The report analyzes the global molecular diagnostics market on a global scale and its various segments and also provides detailed information regarding the key umbrella markets including the diagnostics and IVD industry. It further discusses the various industry trends, growth drivers and challenges faced by the respective industry. In addition to the market contention prevalent in the global molecular diagnostics market, major industry players are profiled.

Key Topics Covered

1. Diagnostics: An Overview

1.1 In Vitro Diagnostics

1.2 Molecular Diagnostics

2. Diagnostics Market Structure

See original here:
Research and Markets: Global Molecular Diagnostics Market Report: 2013 Edition

Recommendation and review posted by Bethany Smith

Feng Zengkun

The Straits Times

Publication Date : 27-07-2013

Scientists in Singapore have identified a gene which worsens breast cancer, in a development which could lead to more effective treatment

Scientists in Singapore have identified a gene which worsens breast cancer, in a development which could lead to more effective treatment.

Scientists in Singapore have identified a gene which makes an aggressive form of breast cancer even worse, in a development which could lead to more effective drugs to treat it.

Patients with triple negative breast cancer, whose tumours have high levels of a gene called UBASH3B, are likely to have earlier relapses within three years of treatment.

Scientists at the Agency for Science, Technology and Research's Genome Institute of Singapore (GIS) also said that the cancer in these patients' is more virulent and spreads faster in the body.

View original post here:
S'pore scientists identify gene that worsens breast cancer

Recommendation and review posted by Bethany Smith

Royal Baby: Crowds congratulate Prince Charles and the Duchess of Cornwall
Cheering crowds offered their congratulations to Prince Charles and the Duchess of Cornwall during a visit to Bugthorpe in East Yorkshire. Many people asked ...

By: ITN

Read the original post:
Royal Baby: Crowds congratulate Prince Charles and the Duchess of Cornwall - Video

Recommendation and review posted by Bethany Smith

Monsanto Video Revolt! Must See Animation!
Poor Johnny doesn #39;t like "healthy" food. What could possibly persuade him to eat all his "veggies"? From http://infomaticfilms.com/ and sponsored by http://n...

By: DismantleTheMatrix

Visit link:
Monsanto Video Revolt! Must See Animation! - Video

Recommendation and review posted by Bethany Smith

BIO Presentation Genetic Engineering
For BIO presentation. I do not own any pictures or music.

By: pandabearsweetheaful

Continue reading here:
BIO Presentation Genetic Engineering - Video

Recommendation and review posted by Bethany Smith

Russia is preparing to catch up with the world in the production of genetically modified food. Measures for the development of biotechnology and genetic engineering are laid out in the road map developed by the Ministry of Economic Development. Officials hope to reduce imported biotechnology and increase the presence of the Russian Federation in this promising market.

Today, the share of Russia's participation in the rapidly developing but highly controversial biotechnology segment of the market is less than 0.1 percent. Meanwhile, analysts do not doubt the prospects of this trend. According to their projections, by 2025 the world market of GMOs will reach $2 trillion. According to Russian officials, by that time Russia will fully establish its own production of genetically-modified foods to get a larger piece of this pie.

The road map for the development of biotechnology in the country is available on the official website of the government of the Russian Federation. The proposed measures include biopharmaceuticals, industrial biotechnology, agricultural and food biotechnology, forest biotechnology, bioenergy, environmental biotechnology and genetic engineering. The road map suggests that five years later, by 2018, the production of biotechnological products in Russia will reach the following volumes: in terms of consumption - 300 billion rubles compared to 128 billion in 2012, in terms of production - 200 million rubles against the current 26 billion, in terms of exports - 50 billion rubles compared to 1 billion rubles last year.

According to the industry experts, today China provides the most serious funding for GMO research. Germany and France are also focusing on the development of biotechnology, and so do Italy and the United States, albeit to a lesser extent. Interestingly, even for Germany, whose government is "preaching" environmental values and maintaining appropriate policies, the development of GMOs does not raise questions. Meanwhile, the vast majority of people in Russia is still convinced of the disastrous effect of genetically modified foods on human health. Experts in the field of science and technology industry do not share these concerns.

"Food industry representatives have long known that no sausage can be made without soy, it is impossible - it will be tasteless, ugly, and so on. So the future of humanity, of course, is in the increase of the production of food products, including through GMO," Vladimir Rudashevsky, deputy chairman of the RSPP Committee on industrial policy and the regulation of natural monopolies and the deputy chairman of the Committee for Scientific and Technological Innovation and high technology told Pravda.Ru. "I think there is a lot of false information on how bad it is. We remember from history that at one time (100 years ago, probably) it was believed that it is impossible to use additives that are widely used now. 300 years ago people could not use pepper - it was thought that it was a deadly poison. This is not the first such experience for the mankind. There is a great deal of bias against everything new (especially with regard to food."

According to Rudashevsky, it is the development of GMOs that allows manufacturers to fully control food, which is nearly impossible in the current state of affairs. A biologist and scientific expert of Pravda.Ru Anton Evseev agrees with this opinion: "As for the stir caused by many media outlets about the danger of the GMPs (genetically modified plants), everyone who writes about it forgets one simple thing - genetic modification is a natural process that occurs in nature several times a day. In fact, people adopted the idea of genetic modification from microorganisms. Symbiotic and parasitic bacteria and fungi as well as viruses are constantly introducing its DNA into crops. We then eat these natural GMO foods and nothing bad happens to us, we do not die and do not mutate. Moreover, if we look at the problem from this point of view, the process of artificial modification is much more secure than the natural one. We know exactly what scientists are introducing into the plant genome, but never know for sure what the bacteria "stuffs" the plants with. I think we can all agree that a controlled modification is always safer than uncontrolled. "

Russia's potential in the development of biotechnology is very significant. According to Vladimir Rudashevsky, these developments were started by Soviet scientists. To date, Russia has a very powerful biotechnology that, however, does not receive the support required for the development of the best examples of GMO products.

"Without developing our own market, we are giving in to the overseas markets, but here lies a great danger. GMOs coming from China and India, I think, are not as good as we would like, because that's where the technology for these products is poorly controlled. We cannot reject them, so the only way to stop it is to develop our own industry based on the principles of good faith, and we have a perfect scientific basis for this," noted Rudashevsky. He added that Pushchinsky State Science and Research Institute and the Institute of Nutrition used to be involved in this type of work.

According to the expert, the approved road map should attract foreign researchers who for one reason or another are not allowed to work on the development of biotechnology in their country. Provision of a platform for the new developments will help Russia to take a fundamentally new spot on the world stage. However, according to scientists, the creation of food through genetic modification is justified not only from the economic point of view.

More:
Russians to proudly poison themselves with their own GM food

Recommendation and review posted by Bethany Smith

Public release date: 26-Jul-2013 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 x2156 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, July 26, 2013 -- Researchers have generated functional hepatocytes from human stem cells, transplanted them into mice with acute liver injury, and shown the ability of these stem-cell derived human liver cells to function normally and increase survival of the treated animals. This promising advance in the development of cell-based therapies to treat liver failure resulting from injury or disease relied on the development of scalable, reproducible methods to produce stem cell-derived hepatocytes in bioreactors, as described in an article in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Stem Cells and Development website.

Massoud Vosough and coauthors demonstrate a large-scale, integrated manufacturing strategy for generating functional hepatocytes in a single suspension culture grown in a scalable stirred bioreactor. In the article "Generation of Functional Hepatocyte-Like Cells from Human Pluripotent Stem Cells in a Scalable Suspension Culture" the authors describe the method used for scale-up, differentiation of the pluripotent stem cells into liver cells, and characterization and purification of the hepatocytes based on their physiological properties and the expression of liver cell biomarkers.

David C. Hay, MRC Centre for Regenerative Medicine, University of Edinburgh, U.K., comments on the importance of Vosough et al.'s contribution to the scientific literature in his editorial in Stem Cells and Development entitled "Rapid and Scalable Human Stem Cell Differentiation: Now in 3D." The researchers "developed a system for mass manufacture of stem cell derived hepatocytes in numbers that would be useful for clinical application," creating possibilities for future "immune matched cell based therapies," says Hay. Such approaches could be used to correct mutated genes in stem cell populations prior to differentiation and transplantation, he adds.

"The elephant in the room for stem cell therapy rarely even acknowledged let alone addressed in the literature is that of scalable production of cells for translational application," says Editor-in-Chief Graham C. Parker, PhD, research professor, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine. "Baharvand's groups' landmark publication not only demonstrates but exquisitely describes the methodology required to scale up stem cell populations for clinical application with a rigor to satisfy necessary manufacturing standards."

###

About the Journal

Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. Complete tables of content and a free sample issue may be viewed on the Stem Cells and Development website.

About the Publisher

Continue reading here:
Human stem cell-derived hepatocytes regenerate liver function

Recommendation and review posted by Bethany Smith

Newswise PHILADELPHIAHenry R. Kranzler, MD, a professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania whose work has contributed to the identification of genetic risk factors and pharmacological treatments for drug and alcohol dependence, has been named the Director of the Center for Studies of Addiction.

Dr. Kranzler received his medical degree from Robert Wood Johnson Medical School and completed a psychiatric residency and a fellowship in alcohol research at the University of Connecticut Health Center. He came to Penn Medicine in 2010 after a lengthy career at the University of Connecticut, where he was an Associate Scientific Director of the Alcohol Research Center, Program Director of the Lowell P. Weicker General Clinical Research Center, and Associate Dean for Clinical and Translational Research. Since 1987, Dr. Kranzlers research has been funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA).

His contributions to the field of alcohol research include advancing clinical trials methodology as it relates to pharmacological treatment, the identification of interactive effects of serotonergic medications with alcoholism subtypes, the use of a targeted approach to naltrexone treatment of heavy drinkers, and the development of long-acting naltrexone as a treatment option.

In addition, his work has contributed to the identification or characterization of specific genes influencing the risk for dependence on alcohol, nicotine, cocaine, and opioids; the potential mechanism of the effects of alcohol through mediators such as neuroactive steroids, and genetic moderators of the response to alcohol treatment.

He has authored or co-authored more than 400 journal articles, book chapters, and other publications. He chaired the NIAAA Clinical and Treatment Subcommittee, has been a frequent journal reviewer, and is a member of the editorial boards of five journals.

The Center for Studies of Addiction, which was established in 1971 as a clinical research and treatment center for addictive disorders, consists of a multidisciplinary group of faculty and staff that conducts research on the etiology and pathogenesis of addictions, as well as clinical trials of pharmacologic and psychotherapeutic treatments for a variety of addictive disorders.

For the past 40 years, the Center has received funding from the NIDA and the NIAAA. It has played a pivotal role in the development of a number of widely used assessments and medication approved by the Food and Drug Administration to treat addictive disorders. In addition to its successful research and research training efforts, the Center has developed highly regarded clinical training programs for medical students, psychiatric residents and addictions fellows.

The Perelman School of Medicine has been consistently ranked among the top 5 nationally by the US News and World Reports for Drug and Alcohol Abuse.

Dr. Kranzler will replace Charles P. OBrien, MD, the founding Director of the Center for Studies of Addiction and one of the foremost addiction psychiatrists in the world. Under Dr. OBriens leadership, the Center, which began at the Philadelphia VA Medical Center and expanded to its current prominent position at Penn, has served as a national resource for the empirical validation of assessment and treatment methods and training in these methods, and in the dissemination of knowledge to the addictions treatment and research communities.

Dr. OBrien will continue his funded research and will serve as a collaborator and mentor to his many colleagues in the Center.

View original post here:
Henry R. Kranzler, MD, Named Director of Penn's Center for Studies of Addiction

Recommendation and review posted by Bethany Smith

Genetics of Reproductive Traits
In general Reproductive Traits are lowly heriatable, so the idea of genetic markers or overall fertility is questionable. However the genes involved in the d...

By: SDSUiGrow

Read this article:
Genetics of Reproductive Traits - Video

Recommendation and review posted by Bethany Smith

Seminar: Gene Silencing using Polypurine Reverse Hoogsteen Hairpins (Carles Ciudad, PhD)
Watch the presentation on Slideshare: http://www.slideshare.net/VHIR/carles-ciudad Seminar led by Carlos Ciudad, PhD, Full Professor of Biochemistry and Mole...

By: VHIRtv

Read more:
Seminar: Gene Silencing using Polypurine Reverse Hoogsteen Hairpins (Carles Ciudad, PhD) - Video

Recommendation and review posted by Bethany Smith

Metal Gear Solid Twin Snakes - Snake vs Metal Gear Rex, Grey Fox, Genes!
Liquid then climbed aboard REX, giving Snake no option but to destroy it. In addition, he also learned from Roy Campbell that if Snake failed to destroy REX,...

By: Kacchi90

See the rest here:
Metal Gear Solid Twin Snakes - Snake vs Metal Gear Rex, Grey Fox, Genes! - Video

Recommendation and review posted by Bethany Smith

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending Now Just Explain It The Upbeat Local Popular Search Keyword News Search Featured Videos Photos Just Explain It Katie's Take Weather The Upbeat Newsmakers

View post:
NIH Begins Gene Therapy Trial for Parkinson s Disease

Recommendation and review posted by Bethany Smith

Personalized Medicine: Collaboration Fosters New Discoveries in the Lab and Treatments for Patients
The unveiling of the complete sequence of the human genome is providing exciting new insights into human biology and disease - discoveries that will translat...

By: schoolofmedicine

See more here:
Personalized Medicine: Collaboration Fosters New Discoveries in the Lab and Treatments for Patients - Video

Recommendation and review posted by sam

Abhishek Narain Singh, Bioinformatics Component in Personalized Medicine, BioComp #39;13, USA
Abhishek Narain Singh, Bioinformatics Component in Personalized Medicine, BIOCOMP #39;13, The 14th International Conference on Bioinformatics and Computational B...

By: abynarainsingh

Read the rest here:
Abhishek Narain Singh, Bioinformatics Component in Personalized Medicine, BioComp'13, USA - Video

Recommendation and review posted by sam

OT Spinal Cord Injury PSA
Courtney Twork.

By: Courtney Twork

Read the original:
OT Spinal Cord Injury PSA - Video

Recommendation and review posted by sam